Literature DB >> 10551886

Depalmitoylation of endothelial nitric-oxide synthase by acyl-protein thioesterase 1 is potentiated by Ca(2+)-calmodulin.

D C Yeh1, J A Duncan, S Yamashita, T Michel.   

Abstract

Protein palmitoylation represents an important mechanism governing the dynamic subcellular localization of many signaling proteins. Palmitoylation of endothelial nitric-oxide synthase (eNOS) promotes its targeting to plasmalemmal caveolae; agonist-promoted depalmitoylation leads to eNOS translocation. Depalmitoylation and translocation of eNOS modulate the agonist response, but the pathways that regulate eNOS palmitoylation and depalmitoylation are poorly understood. We now show that the newly characterized acyl-protein thioesterase 1 (APT1) regulates eNOS depalmitoylation. Immunoblot analyses indicate that APT1 is expressed in bovine aortic endothelial cells, which express eNOS. APT1 overexpression appears to accelerate the depalmitoylation of eNOS in COS-7 cells cotransfected with eNOS and APT1 cDNAs. Additionally, purified recombinant APT1 depalmitoylates eNOS assayed in biological membranes isolated from endothelial cells biosynthetically labeled with [(3)H]palmitate or COS-7 cells transfected with eNOS cDNA. More important, the APT1-catalyzed depalmitoylation of palmitoyl-eNOS is potentiated by Ca(2+)-calmodulin (CaM), a key allosteric activator of eNOS. In contrast, APT1-catalyzed depalmitoylation of the G protein Galpha(s) is unaffected by Ca(2+)-CaM. Furthermore, caveolin, a palmitoylated membrane protein, does not appear to be a substrate for APT1. Taken together, these results support a role for APT1 in the regulation of eNOS depalmitoylation and suggest that Ca(2+)-CaM activation of eNOS renders the enzyme more susceptible to APT1-catalyzed depalmitoylation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10551886     DOI: 10.1074/jbc.274.46.33148

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  64 in total

1.  ACh-induced endothelial NO synthase translocation, NO release and vasodilatation in the hamster microcirculation in vivo.

Authors:  Xavier F Figueroa; Daniel R González; Agustín D Martínez; Walter N Durán; Mauricio P Boric
Journal:  J Physiol       Date:  2002-11-01       Impact factor: 5.182

2.  A cell-specific, prenylation-independent mechanism regulates targeting of type II RACs.

Authors:  Meirav Lavy; Keren Bracha-Drori; Hasana Sternberg; Shaul Yalovsky
Journal:  Plant Cell       Date:  2002-10       Impact factor: 11.277

3.  Functional interaction of endothelial nitric oxide synthase with a voltage-dependent anion channel.

Authors:  Jianxin Sun; James K Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-12       Impact factor: 11.205

Review 4.  Subcellular targeting and trafficking of nitric oxide synthases.

Authors:  Stefanie Oess; Ann Icking; David Fulton; Roland Govers; Werner Müller-Esterl
Journal:  Biochem J       Date:  2006-06-15       Impact factor: 3.857

5.  Acylation of CD44 and its association with lipid rafts are required for receptor and hyaluronan endocytosis.

Authors:  Sai P Thankamony; Warren Knudson
Journal:  J Biol Chem       Date:  2006-08-30       Impact factor: 5.157

6.  MicroRNA-mediated regulation of synaptic palmitoylation: shrinking fat spines.

Authors:  Damien Carrel; Bonnie L Firestein
Journal:  Nat Cell Biol       Date:  2009-06       Impact factor: 28.824

Review 7.  The metabolic serine hydrolases and their functions in mammalian physiology and disease.

Authors:  Jonathan Z Long; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2011-06-23       Impact factor: 60.622

Review 8.  Sphingosine-1-phosphate and modulation of vascular tone.

Authors:  Junsuke Igarashi; Thomas Michel
Journal:  Cardiovasc Res       Date:  2009-02-20       Impact factor: 10.787

9.  Coordinated endothelial nitric oxide synthase activation by translocation and phosphorylation determines flow-induced nitric oxide production in resistance vessels.

Authors:  Xavier F Figueroa; Daniel R González; Mariela Puebla; Juan P Acevedo; Daniel Rojas-Libano; Walter N Durán; Mauricio P Boric
Journal:  J Vasc Res       Date:  2013-11-05       Impact factor: 1.934

10.  Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy.

Authors:  Danielle M Trappanese; Yuchuan Liu; Ryan C McCormick; Alessandro Cannavo; Gayani Nanayakkara; Marina M Baskharoun; Harish Jarrett; Felix J Woitek; D Michael Tillson; A Ray Dillon; Fabio A Recchia; Jean-Luc Balligand; Steven R Houser; Walter J Koch; Louis J Dell'Italia; Emily J Tsai
Journal:  Basic Res Cardiol       Date:  2014-12-06       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.